Summary: An enzyme immunoassay for the determination of human urinary kallikrein has been developed and is compared with other human urinary kallikrein assays such äs radioimmunoassay, dog blood pressure assay, rat uterus test after kinin liberation and synthetic Substrate 2 ) tests (AcPheArgOEt and S-2266). The usable ränge of the Standard curve is from 0.05 to 12 ng kallikrein per test. The intfaassay coefficient of Variation is between 2 and 4%, the interassay coefficient of Variation is between 4 and 12%, and the recovery of auth^ntic kallikrein added to urine samples is 95%. Human saliva and human pancreatic kallikrein show the same binding curves äs purified human urinary kallikrein. Kallikrein from urine of rats, dogs and rabbits äs well äs boar acrosin and pig pancreatic kallikrein, bovine trypsin and chymotrypsin show no cross-reactivity. 
Recently, a radioimmunoassay has been developed for the determination of human urinary kallikrein (11) and since that time this assay has become a common method for the determination of human tissue kallikrein. However, general problems of the radioimmunoassay such äs special and expensive equipment for radioactive measurements and the disposal of radioactive waste stiinulated the development of alternative but also highly sensitive immunoassays. This report describes an enzyme immunoassay for human tissue kallikrein allöwing estimation of kallikrein levels äs low äs 0.5 §/1 in a reasonably short time (5 hours incubation time).
Material and Methods
Human urinary kallikrein, used äs a Standard in the enzyme immunoassay, was purified äs described (12) . Human pancreatic kallikrein was isolated äs described by Hofmann et al. (13 Sample collection 24-hour urine samples of male and female healthy volunteers were collected. The urines were dialysed against running water for 24 h.-Saliva obtained by selective catherization of the glandular duct was collected before and after oral administration of 2 ml citric acid (100 g/l), freeze-dried and stored at -20 °C. Pancreatic juice was collected by a duodenal catheter in a X-ray monitored position. Samples of serum and seminal plasma were obtained from healthy volunteers. Kallikrein activity Human kallikrein activity was measured using DValLeuArgNHNp and AcPheArgOEt äs Substrates (17) . Kallikrein-induced kiriin liberation from human urinary kallikrein by radioimmunoassay was performed according toMann et al. (11) .
Buffers
Biological assay Kinin activity was assayed by the rat Uterus assay äs described by Mann et al. (10) . Bradykinin served äs reference for kinin activity determination. Dog blood pressure assay was performed äs described by Frey et al. (3) .
Coupling of peroxidase to IgG Preparatipn of peroxidase IgG conjugate was performed äs described by Nakane & Kawoi (18) . After gel filtration on Sephadex G-100 the anti-human urinary kälfikrein-IgG peroxidase conjugate was diluted l :50 with buffer C before being used for the enzyme immunoassay.
Enzyme immunoassay conditions Microtiter plates were coated with the sapie anti-human urinary kallikrein-IgG solution (IgG 10 mg/1 buffer) (0.2 ml per well) äs used for the peroxidase IgG conjugate at 4 °C over night. The plates were then washed vigorously (3 times) in buffer B. Human urinary kallikrein Standard samples and test samples were diluted with buffer C. Of these samples 0.2 ml were added to the wells and the plates were incubated at 37 °C for 3 h in order to bind the kallikrein to the solid-phase fixed antibodies. After ineubation, the plates were washed (3 times) with buffer B, 0.2 ml of the anti-human urinary kallikrein-IgG peroxidase conjugate was added to each well, and the plates were incubated again at 37 °C for 2 h; After washing peroxidase activity was measured äs described by Anaokar et al. (19) by addition of 0.2 ml working Substrate solution (stock Substrate consisted of 200 mg ABTS ? ) dissolved in 10 ml water). To prepare working Substrate, 0.5 ml stock solft. was added to 9.5 ml buffer D and 0.2 ml H 2 O 2 solution (H 2 O 2 , 300 g/kg, diluted 0.6 ml/l) was added and the plates were incubated for 30 mifi at room temperature. Thereafter, the reaction was stopped by addition of 0.05 ml sodium azide (10 g/l). The absorption was read photometricaliy at 405 nm with a Microelisa®-reader AM 115 from Dynatech, Denkendorf, West-Germany. Bäckgfouiid generally ranged from 405 nm = 0.02 to 0.08. In each test a Standard concentration curve with purified human urinary kallikrein was inclüded. Standard curves were constructed by plotting the fraction of absorbance at 405 nm, A -N/A 0 -N (A: absorbance, AQ: maximal absorbance obtained with excess human urinary kallikrein, N: absorbance of the blank) against the dose of human urinary kallikrein in a logit-log mpde or in a linear-log mode. A scheme of the incubation conditions is shqwn in Table 1 jugate at which optimal absorbance at 405 nm occurred, this conjugate dilution was chosen for the assay.
Results

Concentration ofthe solid-phase IgG
Time and temperature dependence ofthe antigen antibody reactions
To determine the optimal incubation conditions for the enzyme immunoassay the time and temperature dependence of the first incubation, the binding of human urinary kallikrein to the solid-phase fixed antibody, was studied at 22 and 37 °C. The highest binding rate was observed at 37 °C, where equilibrium was reached after 3 hours (fig. 2a) . The optimal time and temperature required for the second reaction, binding of antihuman urinary kallikrein-IgG peroxidase conjugate to solid-phase immunglobulin-fixed human urinary kallikrein, was simüarily determined. As shown in figure 2b, this time equilibrium was reached after 2 hours at 37 °C. Concentration ofthe IgG-solution used for coating was 10 mg/1, and the anti-human urinary kallikreinJgG peroxidase conjugate dilution was 20-fold.
of IgG ranging from l to 10 mg/1. As seeü in figure l, the Standard curves were identical for IgG concentrations between 10 and 5 mg/1 whereas Standard curves obtained with IgG concentrations lower then 5 rrig/1 showed a decreased binding of human urinary kallikrein. Hence, we decided to use an IgG concentration of 10 mg/1 för the assay. Anti-human urinary kallikreinIgG peroxidase conjugate dilution in the experiment was fixed at a 50-fold dilution.
Anti^human urinary kallikrein-IgG peroxidase conjugate dilution
The optimal dilution of the conjugate was deterrnined from a Standard eürve obtained with microtiter plates coated with an IgG solution of 10 rrig/1 arid conjugate diluted 100,, 50-, 20-and 10-fÖld with büffer C. As the SO-fpld dilution was the highest dilution of the con-
Standard curves and sensitivity
The Standard curve was consistently linear for human urinary kallikrein concentrations between 0.25 and 60 g/l under routine conditions ( fig. 3 ). The sensitivity of an enzyme immunoassay can be defined äs "the smallest amount of antigen giving a response which is distinguishable from the response in the absence of antigen" (20) . The lowest concentration of human urinary kallikrein that produced a response greater than that caused in the absence of human urinary kallikrein was 0.25 Mg/1, which corresponds to 50 pg per well.
Precision
The intraassay coefficient of Variation (N = 10) was 2-4% för human urinary kallikrein (ränge 0.25 to 64 Mg/1). The interassay coefficient of Variation of identical samples (N ^ 10) containing 1,4, 16, 64 /ig/l was 4-12%. 
Speciflcity
Cross-reaction of other serine proteinases with antihuman urinary kallikrein-IgG was tested under the given immunoassay conditions. A cross-reaction was not observed with bovine trypsin and chymotrypsin, pig pancreatic kallikrein, boar acrosin and urine from rat, dog and rabbit. In the human samples investigated, immunologically active material was found in pancreatic juice, saliva, urine, serum and seminal plasma. Suitable dose-response curves are shown in figüre 4.
Recovery fest
Recovery tests in which three different quantities of purified human urinary kallikrein were added to antigenfree rat urine showed a good precision of the assay. The data are listed in table 2. 
Stability ofthe microtiter plätes coated with antihuman urinary kallikrein-IgG
Microtiter plätes coated with anti-human urinary kallikrein-igG were air-dried and stored at 4 °C in sealed plästic bags containing sjlica gel. Identical Standard curves were obtairied under roütine conditions withiri a period of 3 weeks after coating. Tliereafter a decrease of binding was observed. *»
Comparison ofthe enzyme immunoassay with other methods
In order to show the correlation of the enzyme immunoassay with other determination methods for human urinary kallikrein, 10 dialysed urine test samples were measured by different kallikrein assays. As can be seen from figure 5 the correlation coefficients of the synthetic Substrate assays with AcPheArgOEt and DValLeuArgNHNp, the dog blood pressure assay, the kinin-liberation assay, the radioimmunoassay of human urinary kallikrein and the enzyme immunoassay are close to l. (17) 0.9920
Discussion
The sensitive and specific enzyme immunoassay developed for human urinary kallikrein should be especially suitable for further studies on the physiological and pathophysiological rple of tissue kallikreins. As the different tissue kallikreins in humans are imrnunplogically indistinguishable (21) , this assay ean be used to detect all of them.
The high specificy of the epzyme imrnünoassay could be demonstrated by emplpying väriöüs serine protein* ases. Cross reactivity was not obsefved with bpvine trypsin and chymotrypsin, boar acrosin and pig pancreatic kallikrein. Furthermpre, in analögy to the results obtained by radioimmünoassay of human urinary kallikreiri (l 1) we mäy expect that human proteinases pther thäii tissue kallikreins dp not inter* fere in the enzyme immunoassay. · » Dose response curves obtained with immunologieajly crpss-reäcting rnaterial frpm pancreatic juice, serum and seminal plasma were not parallel with each other. These results are in agreement with data obtained using the radioimmunoassay for human urinary kallikrein (l 1), exeept for the binding curves for human pancreatic juice. This is of interest since purified human pancreatic kallikrein will gjve parallel curves in the enzyme immunoassay for human urinary kallikrein. Explanations for these interferences could be the presence of: 1) prokallikrein or rnodified kallikrein with imrnunologjcally different properties, 2) other, äs yet uncharacterized, cross-reacting antigens, and 3) inhibitors in the samples which reduce binding to antibody due to källikrein-inhibitor complex formation.
Further nonspeeific interferences cannot be excluded at present. All these questions need to be further investigated and methods for the elimination interference must be developed.
A number of experiments were undertaken to compare the enzyme immunoassay with assays established already for the determination of human urinary kallikrein. For this purpose dialysed urine samples from 10 different persons were employed. The results obtained with the enzyme immunoassay were compared with those obtained by the dog blood pressure assay, a radioimmunoassay for human urinary kallikrein, a rat uterus assay after kallikrein-induced kinin liberation, and assays with AcPheArgOEt and DValLeuArgNHNp äs kallikrein Substrates. The correlation between the synthetic substrate assays, the rat uterus assay after kallikrein-induced kinin liberation and the radioimmunoassay is more satisfactory than the correlation obtained by comparison of dog blood pressure assay and enzyme immunoassay. Though the correlation coefficient of the results of the enzyme immunoassay and the dog blood pressure assay is rather close to l, a considerable scattering of the data is observed. This is not too surprising, since the coefficient of Variation of the blood pressure assay for kallikrein is approximately 20% (22) . The excellent correlation, however between the twp immunoassays indicates the high validity pf the enzyme immunoassay.
Considerable advantages of the enzyme immunoassay over the radioimmunoassay are, amorig others, the lack öf radiation hazards, greater stability of the label, higher thrpughput and ease of automation. The assay procedure is simple tp perform in a relatively short time and requires only small quantities of kallikrein. The minimal detectable döse is 50 pg per well. Therefore, this assay offers a precise and feasible test for human urinary kallikrein, which can be used äs an alternative to the radioimmunoassay.
